CLX three-lens brief
Evidence-based stock research on CLX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.32% yesterday. · Debt-to-equity of 4876% — balance-sheet-heavy.
- Moved +2.32% yesterday.
- Debt-to-equity of 4876% — balance-sheet-heavy.
- Earnings scheduled 2026-07-30.
CLX closed at $95.23 (+2.32%) as of 2026-07-10. Market cap: $11.52B. P/E (trailing) 15.5. Price is above the 50-day MA and below the 200-day MA. Positives: moved +2.32% yesterday.. Concerns: debt-to-equity of 4876% — balance-sheet-heavy.. Last quarter: Revenue $1.67B, net income $187.00M, free cash flow $62.75M. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on CLX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CLXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CLX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CLX brief"></iframe>